We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZPN
26
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$5.54M 1.08%
146,951
-635
-0.4% -$24K
RVBD
27
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$5.44M 1.06%
293,398
-55
-0% -$1.03K
AZN icon
28
AstraZeneca
AZN
$262B
$5.22M 1.01%
73,014
-341
-0.5% -$25K
CVLT icon
29
Commault Systems
CVLT
$6.12B
$5.15M 1%
102,183
+505
+0.5% +$26K
EXPD icon
30
Expeditors International
EXPD
$23.9B
$5.13M 1%
126,306
+587
+0.5% +$25K
FLIR
31
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$5.05M 0.98%
161,259
-2,037
-1% -$68.4K
ERIC icon
32
Ericsson
ERIC
$32.4B
$4.88M 0.95%
387,279
+2,210
+0.6% +$27.4K
LEG icon
33
Leggett & Platt
LEG
$1.51B
$4.71M 0.91%
134,805
+1,077
+0.8% +$36.9K
CA
34
DELISTED
CA, Inc.
CA
$4.62M 0.9%
165,437
-2,406
-1% -$68.7K
TAL
35
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$4.59M 0.89%
111,359
+2,513
+2% +$112K
ABEV icon
36
Ambev
ABEV
$46.8B
$4.5M 0.88%
687,685
+8,753
+1% +$61.6K
MIC
37
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$4.25M 0.83%
63,791
-2,294
-3% -$160K
TIS
38
DELISTED
Orchids Paper Products, Inc.
TIS
$4.19M 0.81%
170,526
+5,742
+3% +$160K
SVC
39
Service Properties Trust
SVC
$1.11B
$3.91M 0.76%
29,334
+153
+0.5% +$22.1K
GSK icon
40
GSK
GSK
$104B
$3.88M 0.75%
67,618
+473
+0.7% +$29K
BGC icon
41
BGC Group
BGC
$5.41B
$3.67M 0.71%
767,032
-1,104
-0.1% -$5.4K
COHR icon
42
Coherent
COHR
$54.3B
$3.64M 0.71%
309,410
-7,319
-2% -$99.6K
AAPL icon
43
Apple
AAPL
$4.9T
$3.6M 0.7%
143,064
+1,880
+1% +$46.1K
DAR icon
44
Darling Ingredients
DAR
$10B
$3.59M 0.7%
195,821
-17,828
-8% -$345K
BSFT
45
DELISTED
BroadSoft, Inc.
BSFT
$3.56M 0.69%
169,076
-296
-0.2% -$6.99K
CAJ
46
DELISTED
Canon, Inc.
CAJ
$3.56M 0.69%
109,112
+722
+0.7% +$23.9K
KRFT
47
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$3.55M 0.69%
62,908
+913
+1% +$52.8K
MRK icon
48
Merck
MRK
$315B
$3.46M 0.67%
61,250
+592
+1% +$33.2K
CSCO icon
49
Cisco
CSCO
$441B
$3.43M 0.67%
136,245
+2,810
+2% +$70.7K
WBK
50
DELISTED
Westpac Banking Corporation
WBK
$3.4M 0.66%
120,978
+1,088
+0.9% +$34.3K

Similar funds

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.